London: Scientists have identified a small neutralising antibody, a so-called nanobody, that has the capacity to block SARS-CoV-2 from entering human cells. It has the potential to be developed as an antiviral treatment against COVID-19, reported ZeeNews quoting an IANS report.
The study was published in the journal Nature Communications.
“We hope our findings can contribute to the amelioration of the Covid-19 pandemic by encouraging further examination of this nanobody as a therapeutic candidate against this viral infection,” study co-author Gerald McInerney from the Karolinska Institute in Sweden was quoted as saying.
According to the researchers, nanobodies offer several advantages over conventional antibodies as candidates for specific therapies.
They span less than one-tenth the size of conventional antibodies and are typically easier to produce cost-effectively at scale, the report added.
Critically, they can be adapted for humans with current protocols and have a proven record of inhibiting viral respiratory infections, ZeeNews added.
Jammu: An all-round show by Sri Lankan Dilshan Munaweera was not enough for Konark Suryas…
Bhubaneswar: Rohit Patro, a first-year student from the Mathematics department of Central University of Odisha (CUO),…
Bhubaneswar: Durga Puja or Dussehra festival that is celebrated across Odisha has come a long…
New Delhi: Reliance India Limited (RIL) got undue favour courtesy Indian Olympic Association’s (IOA’s) “faulty” sponsorship…
Jajpur: Police have arrested a 60-year-old man for allegedly raping a minor girl in Odisha's…
New Delhi: A day before the first anniversary of Hamas’s October 7 attack, several rockets were…
Cuttack: Two persons allegedly slit the throat of an auto-rickshaw driver following a dispute over…
New Delhi: Ladakh activist Sonam Wangchuk and his supporters launched an indefinite hunger strike at Ladakh…